Loading
institutionsInstitution
Melanoma Institute Australia
Sydney institute treating and studying more melanoma patients than any other centre in the world, whose co-directors Georgina Long and Richard Scolyer led the trials that established combination immunotherapy.
Also called: MIASydney Melanoma Unit
Overview
Melanoma Institute Australia grew out of the Sydney Melanoma Unit and is affiliated with the University of Sydney, Royal North Shore and Mater Hospitals. It treats and follows more melanoma patients than any other centre and holds one of the largest melanoma biobanks. Its co-medical directors, Georgina Long and Richard Scolyer, were Australians of the Year in 2024; Long led the COMBI-AD adjuvant trial and neoadjuvant immunotherapy trials such as NADINA, and Scolyer's pathology work defines how melanoma is staged.
Location
Sydney, AU
Type
research institute · University of Sydney
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#613 · 4 points (0 Newsweek + 0 NCI + 4 from 2 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Melanoma Institute Australia, including child institutions. 722 works · 15,703 citations · 71% open access · 17% clinical trials · 3% reviews.
Oncology works per year
1662022
1442023
1712024
1422025
992026
Most works
- Georgina V. Long243 works
- Richard A. Scolyer198 works
- Serigne Lo143 works
- Alexander Maxwell Menzies123 works
- John F. Thompson103 works
- Matteo Salvatore Carlino96 works
- Alexander C. J. van Akkooi94 works
- Paolo A. Ascierto86 works
- Robyn P.M. Saw78 works
- Andrew John Spillane62 works
Most cited
- Melanoma medical oncology
- Neoadjuvant immunotherapy
- Melanoma pathology and biobanking
Similar pages
- TrialCOMBI-d
Shares Georgina V. Long, Melanoma.
- IdeaTest intermittent dosing of targeted drugs to delay resistance, with honest priors
- Key paperNADINA: two doses of ipilimumab plus nivolumab before surgery beat a year of nivolumab after surgery in stage III melanoma
Shares Georgina V. Long, Melanoma.
- TrialNADINA
Shares Georgina V. Long, Melanoma.
- CancerBRAF V600-mutant melanoma
Shares Georgina V. Long, COMBI-AD, Melanoma.